Edition:
United Kingdom

Catalyst Pharmaceuticals Announces Plans To Resubmit New Drug Application For Firdapse


Monday, 12 Feb 2018 

Feb 12 (Reuters) - Catalyst Pharmaceuticals Inc ::CATALYST PHARMACEUTICALS ANNOUNCES PLANS TO RESUBMIT NEW DRUG APPLICATION FOR FIRDAPSE®.CATALYST PHARMACEUTICALS - CURRENTLY ANTICIPATES RESUBMITTING NDA FOR FIRDAPSE FOR LEMS TO FDA BY END OF Q1 2018.